Fatcow Icon
One Hundred and Eighty-Three Students Named to Tri-County’s President’s List for Fall 2012

PENDLETON —- One hundred and eighty-three students have been named to Tri-County Technical College’s President’s List for fall 2012.

To be eligible for the President’s List, a student must be classified as a degree, diploma, or certificate-seeking student; earn at least 12 credit hours in courses numbered 100 or above; attain a GPR of 4.00; and cannot earn a “F,” “WF,” or “U” grade for courses numbered 100 or below.

ANDERSON COUNTY

FROM ANDERSON:

Jesse Jo Albanese, Associate Degree Nursing; Blaise Michael Beard, Mechatronics Technology; Charles Louis Caler, Management; Marjorie Sullano Cohron, Administrative Support; Kevin Herbert Cox, Machine Tool Technology; Tory Talmadge Dennis, Management; Preston Mark Dickson, Industrial Electronics Technology; Ryan Dale Fields, Machine Tool Technology; Savannah Nancy Gelinas, Associate in Arts; Gregory Charles Gilliland, Associate in Science; Denequa Yulanda Harper, Mechatronics Technology; Dale Henrique, Computer Technology; Cynthia Ruth Jeffcoat, Management; Stephanie Elizabeth Johnson, Radio and Television Broadcasting; Blake Jury, Mechatronics Technology; Robert Chandler Kay, Associate in Arts; Carolyn Annetta Kirkwood, Administrative Office Technology; George Krutitskiy, Associate in Science; Jane E. Kuebler, Associate in Science; Shelby Lorraine Leasure, Early Childhood Development; Sumeyya Shaheen Malik, Associate in Arts; Tasmariah Tasha Nash, Early Childhood Development; Lisa Ann Neighbors, Industrial Electronics Technology; Bhavik Rajendra Patel, Associate in Science; Katie Lynn Price, Associate Degree Nursing; Katherine Linley Owen Smith, Accounting; Amanda Marie Smith, Practical Nursing; Jennifer Dawn Standridge, Administrative Office Technology; Sarah Sinclair Stevens, Associate Degree Nursing; Steven John Sutton, Mechatronics Technology; George Fred Taylor, Management; Anna Cole Thompson, Veterinary Technology; Deborah Lea Wert-Ferner, Management; Mark Wade Wickham, Early Childhood Development; Ronnie Lee Williamson, Criminal Justice Technology; and Niki L. Wright, Management

FROM PENDLETON:

Crystal Louise Brazell, Medical Laboratory Technology; Aimee Jutras Cole, Transition Nursing; and Laura Louise McGarry, Industrial Electronics Technology

FROM PELZER:

Dale McCroskey, Industrial Electronics Technology

FROM PIEDMONT:

Maxwell Pearson Davenport, General Studies; Craig Ellison Davenport, Mechatronics Technology; Darren Brennen Deavers, Associate in Arts; and Jacob Ramsay Plyler, Industrial Electronics Technology

PICKENS COUNTY

FROM CENTRAL:

Lindsey Marie Adam, Associate in Science; Sarah Elizabeth Durham, Accounting; Lindsey Anna Kovarick, Veterinary Technology; Viola Jean Palacios, Early Childhood Development; Kenneth Otto Sisco, Machine Tool Technology; Nicola Jean Whitelightning, Veterinary Technology; and Samuel Chathan Wigley, Associate in Arts

FROM CLEMSON:

Jennifer Lynn Hoffman, Associate in Science; Kiera Elizabeth Johnston, Veterinary Technology; Margaret Jane Jones, Associate in Science; Nicholas Mark Masto, Associate in Science; Dustin Billy Merritt, Associate in Science; Maxwell Gordon Pfeiffer, University Studies; Patricia Margaret Schillaci, Administrative Office Technology; and Amanda Lynn Smith, Administrative Office Technology

FROM EASLEY:

Cetera Le’Royce Alexander, Administrative Office Technology; Sarah Ann Bork, Associate in Science; Evan Blake Bryson, Pre-Pharmacy; Ethan Jerald Cleveland, Mechatronics Technology; Mason Colt Davis, Industrial Electronics Technology; Lauren Brooke Dennis, Associate in Arts; Megan Leigh Dickard, Administrative Office Technology; Justin Lee Gardo, Associate in Science; Jonathan Blake Gravley, Heating, Ventilation, and Air Conditioning Technology; Jessica Ann Gray-Brewer, Welding Technology; Ashley Denise Hare, Management; Kenneth Wayne Higgins, Mechatronics Technology; Adam Griffin Holder, Mechatronics Technology; Robert James Irvine, Associate in Science; Michael Stephen Knight, Industrial Electronics Technology; Jeffrey Aaron Koenen, Management; Bobby Lane McDonald, Computer Technology; Zachary William Girard McIntyre, Associate in Science; Joseph Michael McKenzie, Mechatronics Technology; Joseph Ryan Muth, Radio and Television Broadcasting; Andrew Jeremy Pittman, Expanded Duty Dental Assisting; Zachary Taylor Rhodes, Industrial Electronics Technology; Ashley Ann Riggins, Associate Degree Nursing; Ashley Erickson Riley, Early Childhood Development; Jessica Marie Skelton, Associate Degree Nursing; Lee Anna Stimis, Industrial Electronics Technology; Kayla Nicole Thompson, Associate in Science; Shana Renee Underwood, Early Childhood Development; Kristin Bethany Wilkie, Early Childhood Development; and Dawn Marie Wilson, Administrative Office Technology

FROM LIBERTY:

Janet R Bryant, Associate in Arts; Samantha Lace Crawford, Radio and Television Broadcasting; Suhaylah Faruq, Associate in Science; Jennifer Lynn Gerlach, Early Childhood Development; Eric Ryan Hawkins, Industrial Electronics Technology; Beth Anne Krupp, Expanded Duty Dental Assisting; Tyler Burk Kurth, Computer Technology; Kristin Danielle Lee, Radio and Television Broadcasting; Elizabeth Nichole Norris, Associate in Arts; Luke Allen Ramey, Industrial Electronics Technology; Amy Smith, Associate in Science; and Luciemarie Elizabeth Sturtevant, Management

FROM NORRIS:

Rebecca Erin Tapp, Administrative Office Technology

FROM PICKENS:

Shannon Robin Alexander, Medical Office Specialist; Candace Leigh Ann Atkins, Medical Office Specialist; Jennifer Elizabeth Eades, Associate in Arts; Krysti-Ruth Elizabeth Hannah, Early Childhood Development; Reba Jo Kruse, Associate Degree Nursing; Jennifer Welborn Mitchell, Associate in Arts; Cody Matthew Powell, Industrial Electronics Technology; Beverly Renee Sweet, General Engineering Technology; and Rachel Elizabeth Trainer, Associate in Arts

FROM SIX MILE:

Brandon Richard Anderson, Computer Technology; Davison Scott Medlock, Associate in Science; and Dustin Dean Nealy, Mechatronics Technology

Share This Article |
similar stories

Palmetto names new athletic director, football coach | 28 days ago by Billy Cannada
Staff Writer

Cancer awareness supporters, fundraiser show force | 29 days ago by Lonnie Adamson
General Manager/Editor

State chamber president to speak Thursday | 26 days ago

Summer Sketchbook Workshops Jo Johnston to offer series of workshops at the Hagood Mill | 16 days ago

Some things are worth preserving | 27 days ago

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Photo contest deadline is Friday
COLUMBIA — The deadline is Feb. 15 for the S.C. Department of Commerce’s ninth annual Rural Summi...
Feb 12, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story
Newberry Opera House to host John Michael Montgomery
NEWBERRY — John Michael Montgomery, a Kentucky-born artist whose personal contributions to the st...
Feb 05, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story

News
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More News
Sports
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Sports
Opinion
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Opinion
Latest Video
Weather
Sponsored By:

RSS Feeds
All articles feed
News feed
Sports feed
Videos feed
Obituaries feed
Opinion feed
Local Features
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Local Features
Poll
Sponsored By:

More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
View Previous Polls
Special Sections
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 59 views | 0 0 comments | 17 17 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet